Abstract
Comparing the efficacy of different treatments in psychiatry is difficult for many reasons, even when they are investigated in 'head-to-head' studies. A consensus meeting was, therefore, held to produce best practice guidelines for such studies. This article presents the conclusions of this consensus and illustrates it using published data in the field of antidepressant treatment of generalized anxiety disorder.
| Original language | English |
|---|---|
| Pages (from-to) | 409-416 |
| Number of pages | 8 |
| Journal | Journal of Psychopharmacology |
| Volume | 22 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Jun 2008 |
Keywords
- Clinical trials
- Duloxetine
- GAD
- Non-inferiority
- Venlafaxine
Fingerprint
Dive into the research topics of 'Establishing non-inferiority in treatment trials in psychiatry - guidelines from an Expert Consensus Meeting'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver